Literature DB >> 10550312

Anomalous cadherin expression in osteosarcoma. Possible relationships to metastasis and morphogenesis.

T Kashima1, J Kawaguchi, S Takeshita, M Kuroda, M Takanashi, H Horiuchi, T Imamura, Y Ishikawa, T Ishida, S Mori, R Machinami, A Kudo.   

Abstract

Two isoforms of the human cadherin-11/OB-cadherin gene, the intact and the variant forms, had been isolated from an osteosarcoma cDNA library. The intact form has a typical cadherin structure, whereas the variant form, generated by alternative splicing, encodes a cytoplasmic domain that is completely different from that of the intact form and lacks a homophilic cell-cell adhesion ability. At the protein level, the secreted form generated from the intact cadherin-11 is present. We examined the expression of the intact and the variant forms of cadherin-11 in 23 primary and metastatic osteosarcomas from 22 patients by reverse transcriptase-polymerase chain reaction (RT-PCR) analyses, revealing that all 23 tumors in the patients expressed the variant form and three of them expressed it prominently. On the other hand, Western blot analyses of six tumors showed that the secreted form was strongly expressed, and furthermore, expression of N-cadherin was extremely low. Overexpression of the intact cadherin-11 cDNA in osteosarcoma cell lines demonstrated that the secreted form is derived from the intact form of cadherin-11 in osteosarcoma. Immunohistochemically, cadherin-11, N-cadherin, and beta-catenin were expressed at the cell surface of fetal osteoblasts, whereas in osteosarcoma cells, they were expressed only focally or weakly in the cytoplasm. Considering the function of cadherin in carcinomas, it is suggested that the anomalous expression of human cadherin-11 in osteosarcoma and the reduced expression of N-cadherin play a role in metastasis and the irregular morphology in the highly malignant mesenchymal tumor.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10550312      PMCID: PMC1866957          DOI: 10.1016/S0002-9440(10)65471-5

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  20 in total

1.  The ultrastructure of osteosarcoma. A review of twenty cases.

Authors:  A H Williams; C P Schwinn; J W Parker
Journal:  Cancer       Date:  1976-03       Impact factor: 6.860

2.  Human osteoblasts express a repertoire of cadherins, which are critical for BMP-2-induced osteogenic differentiation.

Authors:  S L Cheng; F Lecanda; M K Davidson; P M Warlow; S F Zhang; L Zhang; S Suzuki; T St John; R Civitelli
Journal:  J Bone Miner Res       Date:  1998-04       Impact factor: 6.741

3.  Overexpression of resistance-related proteins (metallothioneins, glutathione-S-transferase pi, heat shock protein 27, and lung resistance-related protein) in osteosarcoma. Relationship with poor prognosis.

Authors:  H Uozaki; H Horiuchi; T Ishida; T Iijima; T Imamura; R Machinami
Journal:  Cancer       Date:  1997-06-15       Impact factor: 6.860

4.  Soluble 80-kd fragment of cell-CAM 120/80 disrupts cell-cell adhesion.

Authors:  M J Wheelock; C A Buck; K B Bechtol; C H Damsky
Journal:  J Cell Biochem       Date:  1987-07       Impact factor: 4.429

5.  Expression and function of the splice variant of the human cadherin-11 gene in subordination to intact cadherin-11.

Authors:  J Kawaguchi; S Takeshita; T Kashima; T Imai; R Machinami; A Kudo
Journal:  J Bone Miner Res       Date:  1999-05       Impact factor: 6.741

6.  Regulated expression of cadherin-11 in human epithelial cells: a role for cadherin-11 in trophoblast-endometrium interactions?

Authors:  C D MacCalman; E E Furth; A Omigbodun; M Bronner; C Coutifaris; J F Strauss
Journal:  Dev Dyn       Date:  1996-06       Impact factor: 3.780

7.  Cadherin-11 expressed in association with mesenchymal morphogenesis in the head, somite, and limb bud of early mouse embryos.

Authors:  Y Kimura; H Matsunami; T Inoue; K Shimamura; N Uchida; T Ueno; T Miyazaki; M Takeichi
Journal:  Dev Biol       Date:  1995-05       Impact factor: 3.582

8.  Tumor cell types in osteosarcoma as revealed by electron microscopy. Implications for histogenesis and subclassification.

Authors:  E Grundmann; A Roessner; M Immenkamp
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1981

9.  Simultaneous expression of cadherin-11 in signet-ring cell carcinoma and stromal cells of diffuse-type gastric cancer.

Authors:  T Shibata; A Ochiai; M Gotoh; R Machinami; S Hirohashi
Journal:  Cancer Lett       Date:  1996-02-06       Impact factor: 8.679

10.  Matrix metalloproteinase stromelysin-1 triggers a cascade of molecular alterations that leads to stable epithelial-to-mesenchymal conversion and a premalignant phenotype in mammary epithelial cells.

Authors:  A Lochter; S Galosy; J Muschler; N Freedman; Z Werb; M J Bissell
Journal:  J Cell Biol       Date:  1997-12-29       Impact factor: 10.539

View more
  26 in total

1.  Cadherin-11, a marker of the mesenchymal phenotype, regulates glioblastoma cell migration and survival in vivo.

Authors:  Harpreet Kaur; Polly J Phillips-Mason; Susan M Burden-Gulley; Amber E Kerstetter-Fogle; James P Basilion; Andrew E Sloan; Susann M Brady-Kalnay
Journal:  Mol Cancer Res       Date:  2012-01-20       Impact factor: 5.852

2.  THE RETINOBLASTOMA PROTEIN: A MASTER TUMOR SUPPRESSOR ACTS AS A LINK BETWEEN CELL CYCLE AND CELL ADHESION.

Authors:  B E Engel; W D Cress; P G Santiago-Cardona
Journal:  Cell Health Cytoskelet       Date:  2014-12-18

3.  Cadherin-11 expression patterns in heart valves associate with key functions during embryonic cushion formation, valve maturation and calcification.

Authors:  Jingjing Zhou; Caitlin Bowen; Gloria Lu; Calvin Knapp Iii; Andrew Recknagel; Russell A Norris; Jonathan T Butcher
Journal:  Cells Tissues Organs       Date:  2013-12-20       Impact factor: 2.481

4.  Clinicopathologic significance of β-catenin and matrix metalloproteinase-2 expression in non-small cell lung cancer.

Authors:  Guang-Hu Li; Yong-Sheng Cui; Qi-Yu Wu; Xiong-Ji Zhang; Yu-Fei Gao
Journal:  Med Oncol       Date:  2013-01-05       Impact factor: 3.064

5.  Podoplanin is regulated by AP-1 and promotes platelet aggregation and cell migration in osteosarcoma.

Authors:  Akiko Kunita; Takeshi G Kashima; Atsushi Ohazama; Agamemnon E Grigoriadis; Masashi Fukayama
Journal:  Am J Pathol       Date:  2011-06-12       Impact factor: 4.307

6.  Loss of the retinoblastoma tumor suppressor protein in murine calvaria facilitates immortalization of osteoblast-adipocyte bipotent progenitor cells characterized by low expression of N-cadherin.

Authors:  Volkan Gündüz; Elizabeth Kong; Crystal D Bryan; Philip W Hinds
Journal:  Mol Cell Biol       Date:  2012-04-30       Impact factor: 4.272

7.  Cytoplasmic and/or nuclear staining of beta-catenin is associated with lung metastasis.

Authors:  Keiichi Iwaya; Hitoshi Ogawa; Masahiko Kuroda; Miki Izumi; Tsuyoshi Ishida; Kiyoshi Mukai
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

8.  CDH4 is a novel determinant of osteosarcoma tumorigenesis and metastasis.

Authors:  Qinglian Tang; Jinchang Lu; Changye Zou; Yang Shao; Yan Chen; Swami Narala; Hui Fang; Huaiyuan Xu; Jin Wang; Jingnan Shen; Rama Khokha
Journal:  Oncogene       Date:  2018-04-03       Impact factor: 9.867

9.  Cadherin 11 Promotes Immunosuppression and Extracellular Matrix Deposition to Support Growth of Pancreatic Tumors and Resistance to Gemcitabine in Mice.

Authors:  Ivana Peran; Sivanesan Dakshanamurthy; Matthew D McCoy; Anastasia Mavropoulos; Bedilu Allo; Aimy Sebastian; Nicholas R Hum; Sara C Sprague; Kelly A Martin; Michael J Pishvaian; Eveline E Vietsch; Anton Wellstein; Michael B Atkins; Louis M Weiner; Andrew A Quong; Gabriela G Loots; Stephen S Yoo; Shahin Assefnia; Stephen W Byers
Journal:  Gastroenterology       Date:  2020-12-09       Impact factor: 22.682

10.  CDH11 Regulates Adhesion and Transcellular Migration of Tongue Squamous Cell Carcinoma.

Authors:  Bi-Tan Zheng; Qing-Ling Li; Ting Lan; Jian Xie; You-Guang Lu; Da-Li Zheng; Bo-Hua Su
Journal:  Onco Targets Ther       Date:  2021-07-16       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.